Blockade of CHRNB2 signaling with a therapeutic monoclonal antibody attenuates the aggressiveness of gastric cancer cells
Mitsuro Kanda, Dai Shimizu, Shunsuke Nakamura, Koichi Sawaki, Shinichi Umeda, Takashi Miwa, Haruyoshi Tanaka, Yoshikuni Inokawa, Norifumi Hattori, Masamichi Hayashi, Chie Tanaka, Goro Nakayama, Yohei Iguchi, Masahisa Katsuno, Yasuhiro Kodera
Topics & Concepts
BiologyCancer researchGene knockdownCancerCancer cellMetastasisCell growthGene knockoutPI3K/AKT/mTOR pathwaySignal transductionApoptosisCell biologyGeneGeneticsBiochemistryCytokine Signaling Pathways and InteractionsCancer, Stress, Anesthesia, and Immune ResponsePI3K/AKT/mTOR signaling in cancer